Tomt Inhibitors

The chemical class termed Tomt Inhibitors refers to a varied group of compounds that can indirectly impact the activity of transmembrane O-methyltransferases through the inhibition of methylation-related pathways. These compounds are not selective for Tomt but rather inhibit broader enzymatic processes that include multiple methyltransferases. Compounds such as 3-deazadenosine and sinefungin act by increasing the levels of S-adenosylhomocysteine or competing with S-adenosylmethionine, which are critical cofactors for methylation reactions. Both mechanisms lead to the inhibition of methyltransferase activity. Adenosine dialdehyde and methylthioadenosine exert their effects by targeting S-adenosyl-L-homocysteine hydrolase, thereby influencing methylation reactions indirectly. Decitabine and 5-azacytidine are nucleoside analogs that incorporate into DNA and trap DNA methyltransferases, which could potentially affect other methyltransferases, including Tomt.

Other compounds, such as RG108, BIX-01294, and hydralazine, are known for their inhibitory effects on DNA methylation but may also interfere with other methylation processes. Procainamide and disulfiram, while having primary targets unrelated to methylation, have been shown to inhibit DNA methyltransferases and could conceivably affect Tomt. Lastly, nicotinamide is a vitamin B3 form that inhibits sirtuins, a class of deacetylases; such inhibition might influence the availability of acetyl groups, thereby indirectly affecting methyltransferase activity, including that of Tomt.